In Vitro Resistance Profile for GS-1720, a Potent Once-Weekly Oral INSTI in Clinical Development
CROI 2025 SF March 9-12
Derek Hansen1, Matthew R. Hendricks1, Brie Falkard1, Joseph Campbell1, Gregg Schwarzwalder1, Ana Z. Gonzalez1, Tomas Cihlar1, Stephen R. Yant1
1Gilead Sciences, Inc., Foster City, CA
